ask="1.69"
ask_size="200"
average_daily_volume="295502"
bid="1.33"
bid_size="1200"
book_value="0.51"
change="-0.04"
change_from_200_day_moving_average="0.14"
change_from_50_day_moving_average="0.15"
change_from_52_week_high="-1.51"
change_From_52_week_low="0.48"
change_in_percent="-2.82%"
close="1.38"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-1.29"
ebitda="0.00"
eps_estimate_current_year="-0.98"
eps_estimate_next_quarter="-0.25"
eps_estimate_next_year="-1.02"
ex_dividend_date="N/A"
float_shares="11469000"
high="1.44"
high_52_weeks="2.89"
last_trade_date="1/30/2017"
last_trade_price="1.38"
last_trade_size="439"
last_trade_time="4:00pm"
low="1.30"
low_52_weeks="0.90"
market_capitalization="27.83M"
moving_average_200_day="1.24"
moving_average_50_day="1.23"
name="Viking Therapeutics
Inc."
notes="N/A"
one_year_target_price="7.56"
open="1.42"
pe_ratio="N/A"
peg_ratio="-0.04"
percent_change_from_200_day_moving_average="+11.07%"
percent_change_from_50_day_moving_average="+11.87%"
percent_change_from_52_week_high="-52.25%"
percent_change_from_52_week_low="+53.16%"
previous_close="1.42"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="2.76"
price_per_sales="N/A"
revenue="N/A"
shares_outstanding="20170000"
short_ratio="0.88"
stock_exchange="NCM"
symbol="VKTX"
volume="219444"
weeks_range_52="0.90 - 2.89"
